8-K: United States Antimony Corporation Registers Shares for Potential Sale Under Existing Agreement

United States Antimony Corporation filed a prospectus supplement to register shares of its common stock for potential sale under its existing sales agreement with A.G.P./Alliance Global Partners.

Summary

• United States Antimony Corporation (UAMY) filed a prospectus supplement with the SEC on April 25, 2025, to register shares of its common stock.
• The shares are issuable under the Sales Agreement dated November 12, 2024, between UAMY and A.G.P./Alliance Global Partners.
• The filing includes an opinion and consent from Hall Booth Smith, P.C. regarding the validity of the shares.
• This report does not constitute an offer to sell or a solicitation to buy securities in any jurisdiction where such action would be unlawful.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It outlines the registration of shares for potential sale, which is neither inherently positive nor negative.

Future Outlook

The document does not contain specific forward-looking statements beyond the registration of shares for potential future sale.

Industry Context

This announcement is a routine regulatory filing related to an existing sales agreement, which is a common practice for companies to raise capital.

Stakeholder Impact

• Shareholders may experience dilution if the registered shares are sold.
• The company may gain additional capital if the shares are sold.

Key Dates

Keywords

common stock, registration, prospectus supplement, sales agreement, UAMY, United States Antimony Corporation, A.G.P./Alliance Global Partners